Alcon's first 330,000 sq. ft. ophthalmic pharmaceutical manufacturing plant in Singapore is now under construction and is targeted for completion in 2012.
Alcon's first 330,000 sq. ft. ophthalmic pharmaceutical manufacturing plant in Singapore is now under construction and is targeted for completion in 2012.
It will serve the Asian markets and according to Alcon's senior vice president for global manufacturing and technological operations, Ed McGough: "With the rapid growth we are experiencing in Asia, this new Singapore plant is integral to our ability to meet the increasing demand for our products in the region. The strategically positioned Singapore location, coupled with the increased capacity of this plant, will help us supply Asia with essential eye care pharmaceuticals more efficiently, and maintain the high-quality service our customers have come to expect from Alcon."
Alcon Singapore operations were established in 1992. Currently the company employs 40 staff and it's anticipated that the new plant will create 150 new jobs.
AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute
October 24th 2024During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.